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Abstract
Abdominal aortic aneurysm (AAA) is a potentially fatal disease and survival rate is very 
low when rupture occurs. Experimental models related with abdominal aortic aneurysm 
are performed on intact and ruptured aneurysm (RAAA) models. By using AAA models; 
complex mechanisms of aneurysm formation, aneurysm progression, chance of rupture, 
preventative and treating methods are researched. Most commonly used methods for 
creating aneurysm are utilization of transgenic or knockout animals; intra/extraluminal 
pharmacologic treatments such as elastase, calcium chloride or angiotensin II; hyperlip-
idemic diet application and surgical interventions such as xenograft, stenosis or graft. 
Pathogenesis of aneurysm is predominantly examined on rodents whereas studies aimed 
at development of treatment modalities such as surgical or endovascular interventions 
are predominantly performed on large animals like rabbit, porcine or dog. Experimental 
studies modeling aneurysm rupture (RAAA) simulate shock (total hypoperfusion) 
occurred due to rupture and ischemia/reperfusion (I/R) occurred due to surgical treat-
ment; without creating aneurysm. In this model, end organ or distal organ injuries and 
methods for reducing these injuries or their hemodynamic effects are investigated by 
creating shock +I/R.
Keywords: abdominal aortic aneurysm, ruptured abdominal aortic aneurysm, 
experimental models, elastase, rat
1. Introduction
Abdominal aortic aneurysm is a degenerative disease characterized by structural degenera-
tion and progressive dilatation in aorta wall. Progressive increase in arterial diameter results 
with rupture which is a life-threatening condition. Only 50% of cases with ruptured aneurysm 
can reach to hospital and 30–50% of these patients dies in hospital. It is an important health 
problem which has been seen in 5–9% of men and 1–1.3% of women aged 65. It is 10th cause 
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of death in developed countries and its incidence increases as population ages. However, 
complex and multifactorial pathophysiology of AAA has not been thoroughly understood [1].
Many animal models have been developed for understanding pathophysiology of AAAs and 
developing treatment models. It has firstly been incidentally observed by Ponseti IV et al. in 
1952 that medial necrosis, dissection and aneurysm formation occurred after a special diet. 
Abdominal aortic aneurysm has been created with different techniques in many different 
models, its pathophysiology and drugs for preventing aneurysm formation have been inves-
tigated [2].
Among these models, most effective models developed for learning disease progression are 
elastase-based models performed on small animals. Large animal models have been required 
for endovascular or current surgical treatment methods, many surgical models like saccular 
or aortic patch have been developed. Most commonly used models among many different 
AAA animal models, difference between models and their applications will be explained in 
this chapter [3].
2. Pathogenesis of abdominal aortic aneurysm
In this section, pathogenesis of aneurysm will be briefly reviewed for clarify the development 
mechanism of experimental models of abdominal aortic aneurysm (AAA).
2.1. Building stones of aortic wall
2.1.1. Elastin and collagen
Two major building stones of aortic wall are elastin and collagen. Elastin is a structural protein 
produced by fibroblasts. Collagen is a solid, insoluble and fibrous protein which is majorly 
produced by fibroblasts and also produced by cells like chondroblast and osteoblast. Elastin 
is the major lifting structure against aneurysm development whereas collagen is the safety 
barrier which is resistant to high pressure and which provides protection against rupture 
after aneurysm is occurred. Degeneration of elastin and collagen results with aneurysm and 
rupture. Some studies revealed that these two proteins are reduced in intima and media lay-
ers of aneurysmatic aortas [4].
Presence of various mechanisms in development of AAAs which has been known as pro-
gressive dilatation of aortic wall has been well-recognized. Most important one of all factors 
causing degeneration in aortic wall is altered homeostasis between matrix synthesis and deg-
radation due to inflammation. Adventitial and medial inflammatory cell infiltration, elastin 
fragmentation and degeneration, medial attenuation are observed during aneurysm develop-
ment [5].
Collagen synthesis in the media and adventitia layers (especially type I and III) increases 
in favor of repair during first stages of aneurysm formation, then it becomes excessively 
degraded like other extracellular matrix macromolecules such as elastin during late stage 
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and causes aortic rupture. Inflammatory cells like polymorphonuclear neutrophils, T cells, 
macrophages, mast cells, NK cells are present in all layers of aneurysm wall and intraluminal 
thrombus. These cells secrete various humoral-inflammatory factors like cytokines, chemo-
kines, leukotrienes, reactive oxygen species (ROS) and immunoglobulins. Inflammatory cells 
enter to aortic intima and media layers through vasa vasorum vessels. Neovascularization 
and decreased number of smooth muscle cells in medial layer are typical features of aneu-
rysm. Intraluminal thrombus causes functional hypoxia in luminal intima and media layers, 
therefore neovascularization and inflammation increase. Also, inflammatory cells in throm-
bus secrete active proteases like matrix metalloproteinase (MMP-9) and urokinase-type plas-
minogen activator (u-PA). Therefore, AAAs occur as a complex pathology consisted of many 
cellular and humoral mechanisms like inflammatory cells, various enzymes and complement 
system [6].
2.1.2. Cellular and molecular mechanisms
2.1.2.1. Proteases
Elastase is a group of serine endopeptidases which catalyzes degradation of elastin and other 
proteins to simpler molecules; breaks polypeptide chains in the bonds including carbonyl 
group of amino acids; and is secreted from neutrophils and macrophages. α-1 antitrypsin is 
a protease inhibitor and it suppresses elastase activity and protects the tissue from inflam-
mation. Elastase levels have been found to be high in ruptured aneurysms whereas α-1-
antitrypsin levels have been found to be low [7].
Matrix metalloproteinases (MMPs) are homolog peptidases which contain zinc in their active 
region; and can degrade extracellular matrix and basal membrane components. They are 
enzymes playing role in physiological processes like tissue regeneration, morphogenesis and 
wound healing.
Tissue inhibitor of metalloproteases (TIMPs) are antiprotease enzymes. MMPs secretion 
degrades structural proteins of aortic wall. Impaired balance between MMPs and TIMPs plays 
an important role in development of acute and chronic cardiovascular diseases. Important 
MMPs which play an important role in development of AAA are MMP-1, -2, -3, -9, -12 and -13. 
There have been inadequate evidence for other MMPs; however, it has been stated that 
MMP-3 plays a very important role for AAA [8]. Elastin degradation and extracellular matrix 
loss in addition to destruction of smooth muscle cells via MMPs cause media layer thinning 
and aortic dilatation. Especially in enlarged aneurysms, intraluminal thrombus along with 
local inflammation and proteolysis occurs. Local hemodynamic forces and weakened vessel 
wall increases aneurysm enlargement. If wall stress exceeds tensile strength; rupture occurs. 
Inflammation, matrix remodeling and neovascularization reduce tensile strength [9].
Others are serine proteases, tissue plasminogen activators (t-PA, u-PA), plasmin, neutrophile 
elastase, cysteine protease (cathepsin D, L, K and S); also cysteine and serine proteases have 
been shown in all AAAs. Concentrations of dipeptidyl peptidase which is a lysosomal cyste-
ine protease, is found normal at aneurysm wall or abundant in stenotic arterial walls when 
neutrophile elastase and other proteases are activated [6, 10].




Phospholipids play an important role in cell membrane structure; also they have been known 
as very important inflammatory mediators. 5-lipoxygenase (5-LO) and leukotriene C4 syn-
thase levels have been found high in human AAA tissues [11]. Association between AAA 
and cyclooxygenase (COX) and its sub-component prostaglandin E2 (PGE2) has been dem-
onstrated, indometacin which is a non-selective COX inhibitor has been shown as preventing 
AAA created with elastase in rat [12]. PGE2 has been shown to activate IL-6 secretion of 
macrophages in studies performed on human aortic tissue or aortic smooth muscle cells [13].
2.1.2.3. Inflammatory cells
Most commonly seen inflammatory cells among many inflammatory cells identified in AAA tis-
sue are macrophages and it has been known that they play an active role in aneurysm formation 
by many macrophage-mediated inflammatory responses [11, 14]. T and B lymphocytes have 
also identified in AAA tissues and functional insufficiency of CD25+ T regulator cells in AAAs 
patients has been reported [15]. Neutrophils have been identified in both human AAAs and 
animal aneurysm models, also L-selectin which is an adhesion molecule has been shown as an 
important mediator in AAA formation created with elastase in rats. Neutrophil depletion in mice 
with aortic perfusion of elastase led to attenuation of AAAs [16]. In addition, mast cells have also 
been identified in human AAA tissues and animal models. These cells secrete many proteases 
and inflammatory mediators which play role in inflammation and immunity. It has been shown 
that mast cell insufficiency in rat and mouse models decreases aneurysm formation [17].
2.1.2.4. Complement system
Complement activation is an immune response started with classic antigen–antibody reac-
tion, lectin pathway or alternative C3 hydrolysis pathway. Factor B is the most important 
component of alternative pathway whereas C4 is the most important component of both 
classic and alternative pathway. Factor B insufficiency decreases the development of AAA 
created by elastase in rats [18].
2.1.2.5. Cytokines and chemokines
Cytokines regulate expressions of matrix metalloproteases (MMPs), serine proteases and 
cathepsin.
Wıthout a doubt, tumor necrosis factor (TNF)-α has a very important place among many 
cytokines and chemokines which are related with inflammatory response. Increased plasma 
and tissue TNF-α levels have been found in AAA patients. Genetic or pharmacological (with 
infliximab) TNF-α inhibition has been shown to decrease calcium chloride-induced AAA for-
mation in rats [19].
Another cytokine which plays an important role in inflammatory process is transforming 
growth factor (TGF)-β. This cytokine acts as a protector from inflammation and cell death. It 
has been shown that systemic blockage of TGF-β activity causes smooth muscle cell death, 
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elastin degradation and vascular inflammation in AAAs created with angiotensin II in hyper-
cholesterolemic rats with genetic tendency [20, 21].
2.1.2.6. MicroRNAs
MicroRNAs are small and single-stranded RNA molecules which directs genes and complex 
pathophysiologic events in many diseases; and a few of them have been known to contribute 
AAA development. It was found that miR-29b which is one of 3 miR-29s (miR-29a, miR-29b 
and miR-29c) of MicroRNA family is increased in AAA tissues [22]. Another mediator respon-
sible for smooth muscle cell proliferation and apoptosis in aneurysm tissue is miR-21; and its 
overexpression prevents aneurysm formation whereas its inhibition increases [23].
2.1.2.7. Gender-dependent mediators
Male gender is an important risk factor AAAs in humans. In pharmacological aneurysm cre-
ation models of animals, it was observed that aneurysm expansion is more in males and pro-
tection from aneurysm disappeared when female aortas are transplanted to males whereas 
aneurysm diameter reduces when estradiol is given to male rats [24].
2.2. Hemodynamic effects
Hemodynamic forces defines kinetic energy applied on arteries and veins by blood flow. 
Vascular endothelial and smooth muscle cells are constantly exposed to dynamic effect of 
blood flow during blood circulation. Three important hemodynamic components play role in 
AAA pathogenesis.
1. Hydrostatic pressure, perpendicular force acting on the vascular wall.
2. Wall shear stress (WSS), tangential force exerted by moving blood along the axis of flow.
3. Tensile hoop stress, the stress in the aortic wall acting circumferentially and produced by 
the resulting pressure [25].
It is well-known that AAA pathophysiology involves many factors as biological, biochemical 
and biomechanical processes. Although biochemical and biological factors are well-defined in 
AAA, role of biomechanical factors in AAA pathology is still poorly understood.
Altered flow types (turbulence etc.) may contribute aneurysm development by injuring arte-
rial endothelium and increasing progression of arterial wall degeneration. Flow oscillation 
areas and areas with extreme shear stress are correlated with atherosclerosis development in 
aorta. Flow types in AAA have been demonstrated as smooth and laminar or irregular and 
turbulent; however, effects of wall shear stress on aneurysm is still poorly known. Geometry 
of the aneurysm sac and surrounding vasculature (including existence, size and symmetry of 
branches arising near the aneurysm) as well as position of the aneurysm sac relative to parent 
vessel affect intraaneurysmal flow [25, 26].
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Coarctation increases hemodynamic stress on the aortic wall and alters flow dynamics. In 
some studies, it was shown that hemodynamic stress facilitates AAA predisposition and 
flow alterations significantly affect arterial lumen diameter. Also, poststenotic dilatation was 
detected at the area of oscillatory shear stress distal to the cast in some studies [27].
3. Intact aneurysm models
Various experimental models have been used for creating abdominal aneurysm. Pharma-
cological methods, xenograft, large animal models are a few of them. Most commonly used 
pharmacological methods are methods like intraluminal elastase, periaortic calcium chloride 
application, systemic angiotensin II infusions. Application of these models in rodents will be 
explained in detail in a different chapter. It is briefly presented in this part.
3.1. Elastase model
Elastase is a member of serine proteases. Its endoluminal infusion alters the normal structure of 
tunica media by causing elastic fiber destruction. It stimulates receptors which are activated by 
protease in the smooth muscle cells on the aortic wall; therefore inhibits Ca2+ inflow required for 
vascular contraction. This inhibition of smooth muscle contractions causes aortic dilatation [28].
As the response to acute elastase damage, elastic lamellae become fragmented by the leucocytes 
invading media layer; then formation of intraluminal thrombus (ILT) starts due to endothelial 
injury. This process promotes aneurysm growth by causing release of endogenous proteases acti-
vated by fibrinolytic system, activation of MMP-2, secretion of urokinase and leucocyte elastase.
This model can be utilized on animal species like rat, mice, hamster and rabbit (Figure 1). It 
can also be applied on larger species like dogs; however, intra-aortic perfusion, aortic balloon 
angioplasty and simultaneous collagenase infusion may be performed for avoiding problems 
caused by high dose of elastase infusion [28, 29].
Waiting period is approximately 7–14 days after the elastase infusion in rodents. An increase 
over 300% in aortic diameter in first week has been observed in this model. If rupture is not 
occurred in first week, stabilization is occurred at 2–3 weeks due to mesenchymal cells colo-
nized into intraluminal thrombus (ILT) and fibrosis.
Generally, aneurysm development is completed in this time period, also histopathologic changes 
on aortic wall at the level of cellular and inflammatory levels are arised along with mechanic 
dilatation occurred in first week. Relaparotomy is performed at the end of these durations, aortic 
measurements are performed and aorta tissue is excised for histopathologic examinations [30].
3.2. Calcium chloride model
Local CaCl
2
 is applied on adventitial layer without direct intervention to abdominal aorta 
in this model which has firstly been designed for developing aneurysm on rabbit carotid 
artery. Therefore, it is technically easier than intraluminal elastase infusion model. In this 
model which has especially been used in rats, a CaCl
2
-impregnated gauze is directly applied 
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to infrarenal aorta. Calcium ions have high degree of affinity to elastin. After application, 
ionized calcium intracellularly turns into calcium phosphate (CaPO
4
) due to alkaline phos-
phatase activity from vascular smooth muscle cells (vSMC) and this compound precipitates 
as hydroxyapatite crystals in elastin fibers, causing their mechanical degradation. In some 
models, this process is accelerated with applying local phosphate-buffered saline (PBS) 
after CaCI
2
 application. It has also been known that human aneurysm wall calcification is 
caused by these CaPO
4
 crystals. Aortic dilatation in CaCI
2
 model increases with time and it is 
caused by progressive infiltration of mast cells and T lymphocyte to adventitia layer. Vascular 
smooth muscle cells disappear due to calcification and fragmentation in elastic fibers and they 
are replaced by neutrophils [27]. Most important aneurysm formation mechanisms of CaCI
2
 
application are medial degeneration and leucocyte infiltration. Endoluminal and intramural 
thrombus are not seen in these type of aneurysms, also rupture chance is very low. Although 
it is mostly used in mice, it can also be applied on rats and pigs [31].
3.3. Elastase and calcium chloride combined model
It has been developed by Tanaka. In this model, CaCI
2
 application is performed around the 
aorta while intraluminal elastase infusion through femoral artery is being given. CaCI
2
-
impregnated gauze is applied around aorta along with 30 U elastase infusion into aorta 
(Figure 2). Total duration is 20 minutes. Elastase infusion duration is decreased from 120 
to 20 minutes. In this model, it has been reported that no atherosclerosis and intraluminal 
thrombus occurs and it can easily be performed [28].
Figure 1. Intraluminal elastase infusion in rat abdominal aorta.
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3.4. Angiotensin II (AngII) model
In this model, intravascular infusion and aortic exploration are not performed. It is the most 
easily performed aneurysm model on mice. It has been firstly described by Daughtery at 2000. 
It is only used on mice and it is the most frequently used method on this species.
Angiotensin II is a potent vasoconstrictor octapeptide. It is produced from angiotensin I after 
the removal of two amino acids at the C-terminal by angiotensin converting enzyme. It main-
tains blood pressure and body fluid/sodium balance by causing construction of blood vessels.
It has been shown that continuous infusion of angiotensin II causes vascular remodeling; 
especially causes atherosclerosis in transgenic or knockout animals; therefore it is an impor-
tant model for researching AAA development and preventative mechanisms [32, 33].
3.5. Spontaneously mutated and transgenic mice models of AAA
Genetically determined types are Blotchy, Lox (lysyl oxidase) deficiency, MMP-3 or TIMP-
1(tissue inhibitor of matrix metalloproteinase) deficiencies, LDL receptor −/−, ApoE −/−, eNOS −/−, 
C57BL/6 and “transgenic mice overexpressing renin and angiotensin”. Food supplements, dif-
ferent feeding methods or some drugs increase rupture risk of aneurysm. For example, beta-
aminoproprionitrile, sweet pea, diethylstilbestrol, monoamine oxidase inhibitors and hydralazine 
are some of them; and they increase rupture risk by reacting collagen in media layer without 
causing any hemodynamic effect. On the contrary, propranolol and reserpine decrease rupture 
risk by their hemodynamic effect; propranolol also decreases rupture risk by causing connective 
tissue with increasing cross-linkage of elastin.
Figure 2. Intraluminal elastase infusion and adventitial CaCI
2
 application.
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Blotchy Mouse is the mutant with impaired intestinal copper absorption due to X chromo-
some mutation. It is one of the species with spontaneous aneurysm development. Copper is 
co-factor of lysyl oxidase (Lox). Lox plays a role in vascular growth and extracellular matrix 
(ECM) production. Elastin and collagen productions are impaired in Lox-deficient mice, 
neutrophil infiltration in tunica adventitia occurs and spontaneous aneurysm formation is 
seen in male rats in 3 weeks. Elastic fiber fragmentation and disintegration of smooth muscle 
cell layers of aortic wall are seen. Although saccular or fusiform aneurysm formations occur 
through whole aorta in these mice; thoracic aorta is most commonly involved. However; it 
has not been primarily preferred model for experimental aneurysm studies because it usually 
results in spontaneous thoracic aorta rupture [34].
Spontaneous aneurysm development on both abdominal and thoracic aortas is seen in 
MMP-3 and TIMP-1 deficient mice. The importance of MMPs for AAA formation was 
further investigated by Eskandari et al. They demonstrated a protective role for tissue 
inhibitor of metalloproteinase (TIMP)-1 on elastase induced AAA in mice. Compared with 
wild type mice, TIMP-1 deficient mice developed larger AAAs after AAA induction with 
elastase [35].
Although LDL receptor and ApoE deficient mice are more commonly used in atherosclero-
sis studies, suprarenal AAAs may occur when they are fed with high-fat diet for 6 months. 
Adventitia thickening along with media layer injury in these animals prevent rupture. These 
aneurysms are very similar to atherosclerotic aneurysms due to presence of elastin degrada-
tion medial electrolysis, vascular dilatation and necrotic core. Duration of aneurysm devel-
opment can be shortened with pharmacologic methods like intraluminal elastase, periaortic 
CaCI
2
 application or subcutaneous AngII infusion in these mice.
It has been demonstrated that suprarenal AAA occurred with a rate of 25% in ApoE+ eNOS 
deficient mice which had been fed with high-fat diet for 4–6 months. These aneurysms are 
characterized with perimedial thrombotic and fibrous material accumulation [31, 33, 34].
Chronic hypertension was created in transgenic mice by cross-mating with human renin or 
human angiotensin genes, then occurrence of aortic rupture was observed when they were 
fed with water containing 1% sodium chloride. Aortic aneurysm was predominantly occurred 
in aortic arch or juxtarenal segments in these mice [36].
Role of MMPs in AAA formation in genetically altered mice have been defined. It was shown 
that after CaCl
2
-mediated aortic injury was created; aneurysm did not occur in MMP2 −/− and 
MMP9 −/− knockout mice whereas aortic dilatation was decreased in MMP12 −/− mice when 
compared with wild-types. Studies indicating regulation of matrix metalloproteinases by 
TIMPs have been conducted [31, 36].
3.6. Large animal models
Aneurysm models performed on large animals have been predominantly developed for pre-
clinic research of surgical or endovascular treatment methods. Most important of these meth-
ods are Elastase model, xenograft model, graft models (patch, pouch, interposition grafts), 
coarctation model and balloon dilatation model.




This model which has been mostly used on rodents has also been used on large animals. 
Aneurysm occurs due to destruction of medial elastic lamellae. Intraaortic elastase infu-
sion may be applied by reaching aorta through femoral artery without laparotomy, alone 
or with applying methods like balloon angioplasty, collagenase infusion, CaCI
2
 application. 
Aorta aneurysm may be created in swine and dog aortas with this method by creating inti-
mal hyperplasia, medial elastic fiber rupture and matrix degeneration. It is the most similar 
method to human aneurysm without tendency towards rupture [37].
Complications like livedo, lower limb paraplegia, neurologic bladder and rectal prolapse 
may occur in this method. Changes in aortic wall and aneurysmatic dilatation, calcification 
and blood flow are followed with weekly ultrasonographic examination under sedation or 
anesthesia. After 2 weeks, it is possible to transformation of dilatation to an aneurysm (>50%). 
Experiment is terminated at the end of third week; then aortic exploration and necessary 
examinations are performed. It has been reported that chance of rupture is increased in moni-
toring period which exceeds 4 weeks.
3.6.2. Xenograft model
It is also called “decellularized aortic xenograft model”. In this model, aorta implantation between 
two different species is performed. This model is based on vascular smooth muscle cell suppression 
and extracellular matrix immunogenicity between species. In this model, roles of immune system 
and extracellular matrix proteins in aneurysm development can be researched and pharmacologi-
cal or immunologic mechanisms preventing aneurysm development can be examined [38].
3.6.2.1. Experimental application
A 1 cm infrarenal aorta segment of Guinea pig (300–350 g) is excised after ligating collat-
eral branches with median laparotomy under general anesthesia; then it is decellularized 
in sodium dodecyl sulphate (SDS 1%, Sigma, St-Louis, USA) at 37°C for 18 hours. After this 
procedure, it is washed with Triton X-100 solution (Sigma) and process is completed after 
washing four times in 24 hours with 0.1% phosphate buffered-saline (PBS) solution. Xenograft 
prepared with this method is transplanted to Lewis rats in orthotopic position by using 10/0 
sutures with microsurgery method [39]. Decellularized aortic xenograft triggers immune reac-
tions without an acute fatal rejection. All cells on the distal part of aorta are removed during 
donor graft preparation; however, collagen and elastin network of extracellular matrix is pre-
served. Degraded guinea pig extracellular matrix becomes infiltrated by intimal monocytes 
and T-lymphocytes, luminal thrombus along with aortic dilatation starts. AAA occurs due to 
reaction between species in extracellular matrix after 14 days, xenograft destruction may result 
with aortic rupture. Doubling time of aortic diameter is short as 10 days in this model [31, 40].
3.6.3. Graft models
In these models, aneurysm is created by performing biologic or prosthetic graft interposition 
to abdominal aorta. Tubular graft or patch application may be performed. Most frequently 
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used biologic grafts are peritoneum, bovine pericardium, fascia of rectus muscle, jejunum 
whereas prosthetic materials are dacron or polytetrafluoroethylene (PTFE) grafts. Most com-
mon graft application methods are patch model, pouch (saccular aneurysm model), graft 
interposition and coarctation models.
3.6.3.1. Patch graft model
In this experimental model developed on large animals like swine and dog, developing 
new endovascular devices for AAA repair by creating aneurysm similar to human anatomy 
became possible. It is an easily applicable method. Most commonly used one of this method 
is the an elliptic patch application. Patch materials used in this method which is also named 
as anterior patch model are materials such as prosthetic grafts, venous grafts (iliac vein or 
jugular vein), rectus fascia, jejunum treated with glutaraldehyde and gastric serosa.
In this procedure, abdominal aorta is explored between renal artery and iliac bifurcation by 
performing median laparotomy under general anesthesia. One each silicon loops are placed 
on renal arteries and above of aortic bifurcation. Aortic segment is occluded with silicon loops 
after systemic heparin injection (200 U/kg). Inferior mesenteric artery and lumbar arteries are 
temporary closed with mini hemoclips. If juxtarenal aneurysm is created, renal arteries are also 
temporary clamped; then segments of 2–3 mm from edge of incision are longitudinally excised 
by performing 5–10 cm aortotomy. Patch graft is sutured to aortotomy incision with 5/0 prolene 
suture by using continuous technique. Aorta clamps are opened with well-known air removal 
techniques and circulation is restored. Incisions are closed. Aneurysm formation is generally 
seen in first 1 months. Rupture rate varies according to graft types and length of aneurysmatic 
segment. It has been reported that segments whose length is more than 6 cm have a rupture 
rate of 70%. Lowest rupture rate has been seen in iliac vein patches (0%) whereas highest rup-
ture rates have been seen in jejunum patches (100% in 42 hours), jejunum patches treated with 
glutaraldehyde (66% at 11 days) and peritoneal patches (50%, 2 weeks). For preparing perito-
neal patches, peritoneal part is isolated and resected with blunt dissection and it is shaped as an 
ovoid-shaped patch whose length is 5–10 cm and width is 2–3 cm. A double-layered peritoneal 
patch is created after folding the free end on itself. It is kept in saline solution for 30 minutes 
before use, and it is anastomosed with continuous suture like other grafts [41].
3.6.3.2. Saccular aneurysm model
It is an another aneurysm model which has been firstly used by Perini. Biologic or prosthetic 
material used in this model is cut into a material sized 3X6 cm and its both sides are sutured after 
folding it on itself. It becomes a sac sized approximately 3X3 cm; then opening of the sac is anas-
tomosed to an aortotomy sized 3 cm which is created on the anterior part of aorta. Result is a sac-
cular aneurysm. Bovine pericardium is most frequently used material. Venous graft materials or 
prosthetic materials may also be used; however, largest dilatation is acquired with biomaterials.
Swines whose weight are approximately 20 kg are used for applying this model. Similar to 
anterior patch model which uses median laparotomy, aorta between renal arteries and bifurca-
tion is explored. A 3 cm segment is chosen for aneurysm. After administrating IV heparin (with 
a dose of 100 UI/kg), proximal and distal aorta are clamped and 3 cm longitudinal aortotomy is 
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performed on the chosen area; then previously prepared saccular bovine pericardium is anas-
tomosed to this area with continuous technique using 6/0 polypropylene. Result is a saccular 
aneurysm. Retroperitoneum and abdomen are appropriately closed. Stabilization is provided 
a few weeks after surgery, mortality and morbidity of this procedure are low. Continuity of 
aneurysm is followed with Doppler ultrasonography with intervals of 15 days, aorta diameter 
increases by more than 50% and it is most frequently used for evaluating endovascular methods. 
Terminal branches of aorta and lumbar plexus are preserved, partial thrombus formation is seen 
in lumen. Endovascular graft applications may easily be performed on aneurysm formation cre-
ated with this model, it is a good model for endoleak researches due to patency of side branches. 
Most important disadvantages are lack of characteristic features of human aneurysm like ath-
erosclerosis, medial degeneration, medial or adventitial lymphocyte infiltration. Complications 
like renal failure, intestinal perforation, sepsis, iliac artery thrombus may be seen in this model. 
Bovine pericardium is cheaper than synthetic materials because it can be acquired easily [42].
Most frequently used animal in this model due to anatomic and hematologic (coagulation 
and fibrinolytic system) similarity to humans is swine. In addition, it is an easily manipulable 
model. Lipid metabolism, lipoprotein profile, thrombocyte aggregation/thrombus formation 
and fibrin deposits after intimal injury, histologic structure of neointimal are also very similar 
to human. Disadvantages are rapid growth of animal, its low tolerance to anesthesia, high 
cost and possible paralysis due to medullary ischemia. Pericardium used in this model is 
treated with glutaraldehyde for reducing antigenicity and increasing resistance to degenera-
tion. Monitoring is performed with Doppler ultrasonography in this model, other imaging 
modalities like angiography is not required.
3.6.3.3. Interposition grafts
In this model, various types of grafts are interposed to infrarenal area of aorta. Graft whose 
diameter is twofold of abdominal aorta is replaced to aorta after spinal artery are ligated. 
Pigs are generally used and endovascular approaches can be used after two weeks. In this 
model, biologic materials (bovine jugular vein treated with glutaraldehyde), fusiform-shaped 
dacron grafts or PTFE grafts dilated with balloon are used. For creating aneurysm, a 8 mm 
PTFE graft is dilated with balloon until its final diameter reaches 30 mm. Graft which becomes 
fusiform-shaped is anastomosed as it is placed between renal arteries and trifurcation. Caudal 
paraplegia may occur due to ligated spinal arteries. Two lumbar arteries are re-implanted 
through posterior of aorta with Carrel patch technique in endoleak researches. Endovascular 
repair can be done 2 weeks after surgery. Type II endoleak researches can be done after plac-
ing intraluminal pressure transducer into sac during surgery [43].
3.6.4. Stenosing cuff
Aneurysm development can be maintained due hemodynamic effect by creating stenosis at 
the infrarenal area of aorta. Stenosis below renal arteries can be created by nylon tape or 
plastic cuff whose width are generally 5 mm. Dilatation of aortic wall and aneurysm forma-
tion are seen due to turbulent flow after stenosis. This model is generally used together with 
intraluminal elastase infusion and balloon angioplasty.
Abdominal Aortic Aneurysm - From Basic Research to Clinical Practice32
After performing median laparotomy, aortic exploration and entrance right above aortic tri-
furcation; balloon plasty and elastase infusion are performed. Amount of administered elas-
tase when a pig weighting approximately 30 kg is 10 ml; and stenosing cuff is placed below 
renal arteries by performing balloon dilatation after infusion. Presence of palpable thrill on 
aorta is the indicator of adequate stenosis. Parameters like “pulsatility index” which provides 
quantitative measurement of degree of stenosis may also be used [44].
Increase in aortic diameter is expected over 50%. Most important advantage of this model is 
preservation of lumbar arteries. Disadvantages are requirement of laparotomy, occurrence 
of retroperitoneal fibrosis and aneurysm extension limited at proximal [2]. Turbulent flow in 
this model provides appropriate hemodynamic effect for damaging intercellular matrix after 
protective barriers like tunica intima and lamina elastic interna are weakened by elastase and 
effect of balloon; rather than creating aneurysm alone [45].
3.6.5. Balloon dilatation
Balloon dilatation alone cannot produce enough aneurysmatic dilatation in large animal 
models. Therefore, it is always used with elastase or collagenase infusion or sometimes both 
of them. Infrarenal stenosing cuff is also occasionally used with them. High pressure balloons 
with width of 10–12 cm and length of 4 cm are used. Angioplasty balloons produced for 
peripheral arteries may be used for this purpose. Applications can be performed with or with-
out stenting. It is percutaneously performed and whole side branches of aorta are preserved. 
It results with moderate degree of dilatation [2].
4. Ruptured abdominal aortic aneurysm (RAAA) model
Clinical condition occurred in aneurysm rupture is modeled in this experimental model without 
creating a real aneurysm. In this model which has been firstly described by Thomas Lindsay at 
1995, first aneurysm rupture by creating shock, ischemic stage of surgical treatment by placing 
aortic clamp then revascularization and reperfusion processes after removing clamp are mod-
eled. Lindsay identified factors like degree of pulmonary injury, ideal clamping area and dura-
tion by measuring “lung permeability index” and “neutrophil sequestration” levels; he reported 
that highest damage had been observed on rats with created lower torso ischemia due to 1 hour of 
shock + supramesenteric clamp. This model has also been used by various investigators [46, 47].
In experimental RAAA model, hemorrhagic shock studies evaluating hemodynamic effects of 
all kinds of drugs, molecules or resuscitation fluids as well as ischemia/reperfusion researches 
evaluating their effects on remote or end organ injuries can be conducted [48].
Most important features which differ RAAA model from other aortic ischemia/reperfusion 
(I/R) studies or hypovolemic shock studies are initial shock creation and placement of aortic 
clamps on both supramesenteric level and aortic bifurcation level. Total body hypoperfusion 
due to initial hypovolemic shock, lower torso ischemia with aortic clamp and then reperfu-
sion are done by creating both shock and I/R [49–51].
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Therefore an effect stronger than both of them alone is acquired. Besides, most important 
cause of high mortality in RAAA is comorbidity of these two important pathology [52].
Application: Most commonly used animals are rats; however, large animals may also be used. 
Right carotid artery for measuring mean arterial pressure (MAP) and jugular vein for venous 
access are cannulated with cut-down method in anesthetized rats with spontaneous respira-
tion (No 22 cannula) (Figure 3).
Heart rate, MAP, rectal temperature and respiratory rate are monitored. Saline infusion with 
a rate of 3 ml/kg/h is given during whole experiment period for preventing insensible losses. 
Rectal temperature is kept at 36.5°C by using heat lamp. After stabilization is acquired, shock 
is created as MAP is set to 50 mmHg for 60 minutes by drawing blood in plastic injector 
containing standard heparin; aneurysm rupture is simulated and withdrawn blood is kept in 
room temperature (Figure 4).
Blood which will be drawn is calculated as not exceeding 30% of total blood volume. Lower 
torso ischemia is created at the end of 1 hour by clamping abdominal aorta with microvascular 
clamps on superior mesenteric level and iliac bifurcation level after performing median lapa-
rotomy and systemic heparinization (250 U/kg). Half of the withdrawn blood is slowly reinfused 
through venous line; therefore surgical x-clamp and resuscitation are simulated (Figure 5).
Figure 4. Drawing blood from carotid artery to create shock.
Figure 3. Cannulations of jugular vein and carotid artery and monitorization.
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At the end of ischemic period which is 60 minutes long, all of remaining withdrawn blood is 
re-infused right before opening clamp and the subject is left to reperfusion for 120 minutes 
after removing clamps and closing abdomen. During reperfusion period, MAP is kept at 
approximately 100 mmHg and fluid replacement is performed if necessary. Hemodynamic 
values are recorded in every 10 minutes (Figure 6). All given fluids are recorded and most 
commonly used fluid is Ringer lactate. At the end of the period, rats are sacrificed by drawing 
blood method; then necessary blood and tissue samples are collected.
Experiment can be modified with different ways.
Figure 5. Aortic clamps on superior mesenteric and iliac bifurcation levels in rat aorta.
Figure 6. Mean arterial blood pressure during the experiment.




Until today, many animal experimental models have been developed for investigating develop-
ment mechanisms, factor affecting expansion and treatment methods of AAA which has been 
a very common disease with high mortality in community. It is obvious that as the technology 
advances, larger number of studies which are more sophisticated will be needed for both better 
understanding etiopathogenesis and developing less invasive methods for treatment.
Conflict of interest
Author declares that there is no conflict of interests regarding the publication of this paper.
Author details
Zerrin Pulathan
Address all correspondence to: zerrin.pulathan@gmail.com
Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
References
[1] Hoornweg LL, Storm-Versloot MN, Ubbink DT, et al. Meta analysis on mortality of 
ruptured abdominal aortic aneurysms. European Journal of Vascular and Endovascular 
Surgery. 2008;35(5):558-570
[2] Kloster BO, Lund L, Lindholt JS. Induction of continuous expanding infrarenal aortic 
aneurysms in a large porcine animal model. Annals of Medicine and Surgery. Jan 14, 
2015;4(1):30-35
[3] Czerski A, Bujok J, Gnus J, Hauzer W, Ratajczak K, Nowak M, et al. Experimental meth-
ods of abdominal aortic aneurysm creation in swine as a large animal model. Journal of 
Physiology and Pharmacology. Apr 2013;64(2):185-192
[4] Dobrin PB. Pathophysiology and pathogenesis of aortic aneurysms. Current concept. 
Surgical Clinics of North America. 1989;69:687-703
[5] Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A. Novel mechanisms of abdomi-
nal aortic aneurysms. Current Atherosclerosis Reports. Oct 2012;14(5):402-412
[6] Shimizu K, Mitchell RN, Libby P. Inflammation and celluler immune responses in 
abdominal aortic aneurysms. Arteriosclerosis, Thrombosis, and Vascular Biology. May 
2006;26(5):987-994
Abdominal Aortic Aneurysm - From Basic Research to Clinical Practice36
[7] Songhera SS, Hingorani A, Tilson MD. Etiology of abdominal aortic aneurysm. In: 
Ascher E, editor. Haimovici’s Vascular Surgery. 6th ed. USA: Wiley-Blackwell publish-
ing; 2012. pp. 221-232. DOI: 10.1002/9781118481370
[8] Rabkin SW. The role matrix metalloproteinases in the production of aortic aneurysm. 
Progress in Molecular Biology and Translational Science. 2017;147:239-265. DOI: 10.1016/
bs.pmbts.2017.02.002 [Epub Mar 15, 2017]
[9] Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM. Pathophysiology and epidemiol-
ogy of abdominal aortic aneurysms. Nature Reviews. Cardiology. 2011;8:92-102
[10] Pagano MB, Bartoli MA, Ennis TL, et al. Critical role of dipeptidyl peptidase I in neutro-
phil recruitment during the development of experimental abdominal aortic aneurysms. 
Proceedings of the National Academy of Sciences of the United States of America. 
2007;104:2855-2860
[11] Di Gennaro A, Wagsater D, Mayranpaa MI, et al. Increased expression of leukotriene 
C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal 
aortic aneurysm. Proceedings of the National Academy of Sciences of the United States 
of America. 2010;107:21093-21097
[12] Holmes DR, Wester W, Thompson RW, Reilly JM. Prostaglandin E2 synthesis and 
cyclooxygenase expression in abdominal aortic aneurysms. Journal of Vascular Surgery. 
1997;25:810-815
[13] Bayston T, Ramessur S, Reise J, et al. Prostaglandin E-2 receptors in abdominal aor-
tic aneurysm and human aortic smooth muscle cells. Journal of Vascular Surgery. 
2003;38:354-359
[14] Ishibashi M, Egashira K, Zhao Q, et al. Bone marrow-derived monocyte chemoattractant 
protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclero-
sis and aneurysm formation in hypercholesterolemic mice. Arteriosclerosis, Thrombosis, 
and Vascular Biology. 2004;24:174-178
[15] Yin M, Zhang J, Wang Y, et al. Deficient CD4+CD25+ T regulatory cell function in patients 
with abdominal aortic aneurysms. Arteriosclerosis, Thrombosis, and Vascular Biology. 
2010;30:1825-1831
[16] Eliason JL, Hannawa KK, Ailawadi G, et al. Neutrophil depletion inhibits experimental 
abdominal aortic aneurysm formation. Circulation. 2005;112:232-240
[17] Sun J, Sukhova GK, Yang M, et al. Mast cells modulate the pathogenesis of elastase-
induced abdominal aortic aneurysms in mice. The Journal of Clinical Investigation. 
2007;117:3359-3368
[18] Pagano MB, Zhou HF, Ennis TL, et al. Complement-dependent neutrophil recruitment is 
critical for the development of elastase-induced abdominal aortic aneurysm. Circulation. 
2009;119:1805-1813
[19] Xiong W, MacTaggart J, Knispel R, et al. Blocking TNF-alpha attenuates aneurysm for-
mation in a murine model. Journal of Immunology. 2009;183:2741-2746
Experimental Models in Abdominal Aortic Aneurysm
http://dx.doi.org/10.5772/intechopen.79393
37
[20] Wang Y, Ait-Oufella H, Herbin O, et al. TGF-beta activity protects against inflamma-
tory aortic aneurysm progression and complications in angiotensin II-infused mice. The 
Journal of Clinical Investigation. 2010;120:422-432
[21] Dai J, Michineau S, Franck G, et al. Long term stabilization of expanding aortic aneu-
rysms by a short course of cyclosporine a through transforming growth factor-beta 
induction. PLoS One. 2011;6:28903
[22] Maegdefessel L, Azuma J, Toh R, et al. Inhibition of microRNA-29b reduces murine 
abdominal aortic aneurysm development. The Journal of Clinical Investigation. 2012;122: 
497-506
[23] Milewicz DM. MicroRNAs, fibrotic remodeling, and aortic aneurysms. The Journal of 
Clinical Investigation. 2012;122:490-493
[24] Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA. Androgen increases 
AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs 
in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 
2008;28:1251-1256
[25] Dua MM, Dalman RL. Hemodynamic influences on abdominal aortic aneurysm disease: 
Application of biomechanics to aneurysm pathophysiology. Vascular Pharmacology. 
Jul–Aug 2010;53(1-2):11-21
[26] Greve JM, Les AS, Tang BT, Draney Bloome MT, Wilson NM, Dalman RL, Pelc NJ, 
Taylor CA. Allometric sealing of wall shear stres from mice to humans: Quantification 
using cine phase-contrast MRI and computational fluid dynamics. American Journal of 
Physiology. Heart and Circulatory Physiology. Oct 2006;291(4):H1700-H1708
[27] Patelis N, Moris D, Schizas D, Damaskos C, Perrea D, Bakoyiannis C, Liakakos T, 
Georgopoulos S. Animal models in the research of abdominal aortic aneurysms devel-
opment. Physiological Research. Dec 20, 2017;66(6):899-915
[28] Tanaka A, Hasegawa T, Chen Z, Okita Y, Okada K. A novel rat model of abdominal 
aortic aneurysm using a combination of intraluminal elastase infusion and extraluminal 
calcium chloride. Journal of Vascular Surgery. 2009;50:1423-1432
[29] Senemud J, Caligiuri G, Etienne H, Delbosc S, Michel JB, Coscas R. Translational relevance 
and recent advances of animal models of abdominal aortic aneurysm. Arteriosclerosis, 
Thrombosis, and Vascular Biology. Mar 2017;37(3):401-410
[30] Holmes DR, Petrinec D, Wester W, Thompson RW, Reilly JM. Indomethacin prevents 
elastase-induced abdominal aortic aneurysm in the rat. The Journal of Surgical Research. 
Jun 1996;63(1):305-309
[31] Lysgaard Poulsen J, Stubbe J, Lindholt JS. Animal models used to eksplore abdominal 
aortic aneurysms: A systematic review. European Journal of Vascular and Endovascular 
Surgery. Oct 2016;52(4):487-499
[32] Davis FM, Rateri DL, Daughtery A. Mechanisms of aortic aneurysm formation: 
Translating preclinical studies into clinical therapies. Heart. Oct 2014;100(19):1498-1505
Abdominal Aortic Aneurysm - From Basic Research to Clinical Practice38
[33] Kujyaniemi H, Ryer EJ, Elmore JR, Tromp G. Understanding the pathogenesis of abdom-
inal aortic aneurysms. Expert Review of Cardiovascular Therapy. 2015;13(9):975-987
[34] Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arteriosclerosis, 
Thrombosis, and Vascular Biology. 2004;24:429-434
[35] Eskandari MK, Vijungco JD, Flores A, Borensztajn J, Shively V, Pearce WH. Enhanced 
abdominal aortic aneurysm in TIMP-1-deficient mice. The Journal of Surgical Research. 
2005;123(2):289-293
[36] Tsui JC. Experimental models of abdominal aortic aneurysms. The Open Cardiovascular 
Medicine Journal. 2010;4:221-230
[37] Lederman A, Saliture Neto FT, Ferreira R, de Figueiredo LF, Otoch JP, Aun R, da Silva 
ES. Endovascular model of abdominal aortic aneurysm induction in swine. Vascular 
Medicine. Jun 2014;19(3):167-174
[38] Allaire E, Bruneval P, Mandet C, Bacquemin JP, Mitchel JB. The immunogenicity of the 
extracellular matrix in arterial xenografts. Surgery. 1997;122:73-81
[39] Schneider F, Saucy F, de Blic R, Dai J, Mohand F, Rouard H, Ricco JB, Becquemin JP, 
Gervalis M, Allaire E. Bone marrow nesenchimal stem cells stabilize already-formed 
aortic aneurysms more efficiently than vascular smooth muscle cells in a rat model. 
European Journal of Vascular and Endovascular Surgery. Jun 2013;45(6):666-672
[40] Alsac JM, Journe C, Loudec L, Dai J, Julia P, Fabiani JN, Michel JB. Downregulationof 
remodeling enzymatic activity induced by an angiotensin-converting enzyme inhibitor 
(perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a 
rat model. European Journal of Vascular and Endovascular Surgery. Apr 2011;41(4):474-480
[41] Maynar M, Qian Z, Hernandez J, Sun F, DeMiguel C, Crisostomo V, Usón J, Pineda LF, 
Espinoza CG, Castañeda WR. An animal model of abdominal aortic aneurysm created 
with peritoneal patch: Technique and initial results. Cardiovascular and Interventional 
Radiology. Mar–Apr 2003;26(2):168-176
[42] Aquino M de A, Baeeros SM, Castro AA, Pitta GB, Pereira AH. Experimental model of 
saccular abdominal aortic aneurysm in Swines with Pericardium Sac. Brazilian Journal 
of Cardiovascular Surgery. Feb 2016;31(1):70-73
[43] Rhee JY, Trocciola SM, Dayal R, Lin S, Chaer R, Kumar N, Mousa A, Bernheim J, Christos 
P, Prince M, Marin ML, Gordon R, Badimon J, Fuster V, Kent KC, Faries PL. Treatment of 
type II endoleaks with a novel polyurethane thrombogenic foam: Induction of endoleak 
thrombosis and elimination of intra-aneurysmal pressure in the canine model. Journal 
of Vascular Surgery. Aug 2005;42(2):321-328
[44] Lin PY, Wu YT, Shih YH, Sampilvanjil A, Chen LR, Yang YJ, Wu HL, Jiang MJ. Coarctation-
induced degenerative abdominal aortic aneurysm in a porcine model. Journal of Vascular 
Surgery. Mar 2013;57(3):806-815
[45] Molacek J, Treska V, Kobr J, Certik B, Skalicky T, Kuntscher V, Krizkova V. Optimization 
of the model of abdominal aortic aneurysm-experiment in an animal model. Journal of 
Vascular Research. 2009;46:1-5
Experimental Models in Abdominal Aortic Aneurysm
http://dx.doi.org/10.5772/intechopen.79393
39
[46] Lindsay T, Walker P, Romaschin A. Acute pulmonary injury in a model of ruptured 
abdominal aortic aneurysm. Journal of Vascular Surgery. 1995;22:1-8
[47] Harkin DW, Maron CD, Rother RP, Romaschin A, Rubin BB, Lindsay TF. C5 comple-
ment inhibition attenuates shock and acute lung injury in an experimental model of 
ruptured abdominal aortic aneurysm. The British Journal of Surgery. 2005;92:1227-1234
[48] Harkin D, Rubin B, Romaschin A, Lindsay T. Selective inductible nitric oxide (iNOS) 
inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic 
aneurysm. The Journal of Surgical Research. 2004;120:230-241
[49] Shahani R, Marshal J, Barry R, Walker PM, Lindsay TF. Role of TNF-α in myocardial 
dysfunction after hemorrhagic shock and lower-torso ischemia. American Journal of 
Physiology. Heart and Circulatory Physiology. 2000;278:942-950
[50] Lozano FS, Rodriquez JM, Criado FJ, et al. Postoperative evolution of inflammatory 
response in a model of suprarenal aortic cross-clamping with or without hemorrhagic 
shock. Systemic and local reactions. World Journal of Surgery. 2005;29:1248-1258
[51] Lomas-Niera JL, Perl M, Chung CS, Ayala A. Shock and hemorrhage: An overview of 
animal models. Shock. 2005;24(Supp 1):33-30
[52] Lindsay TF, Luo XP, Lehotay DC, Rubin BB, Anderson M, Walker PM, Romaschin 
AD. Ruptured abdominal aortic aneurysm, a “two-hit” ischemia/reperfusion injury: 
Evidence from ananalysis of oxidative products. Journal of Vascular Surgery. Aug 
1999;30(2):219-228
Abdominal Aortic Aneurysm - From Basic Research to Clinical Practice40
